The correlation between genotypes at the position-889C/T in the promoter of interleukin-1 alpha and the severity of coronary heart disease
Yan Li
Abstract
Yan Li
Abstract
Objective To investigate the correlation between the different genotypes at the position -889 in the promoter of interleukin-1 alpha(IL-1α) and the severity of coronary heart disease(CHD). Methods The genotypes of IL-1α(-889C/T)in 118 CHD patients and 184 healthy controls were analyzed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), and The serum level of IL-1α was detected by enzyme-linked immunoabsorbent assay. Results The distribution of IL-1α (-889C/T) genotypes between myocardial infarction(MI) patients and healthy controls was significantly different (χ 2=5.96, P 0.01). CT or TT genotype carriers were at increased risk with an odds ratio of 2.39 for MI(OR=2.39, 95%CI=1.17~4.86). In CHD group, the IL-1α level in patients with CT genotype (13.51±6.85) ng/L was significantly higher than those with CC genotype[(8.04±4.47) ng/L; P 0.001].Conclusion The CT genotype at position -889 in IL-1α is associated with the severity of CHD, and the DNA mutation at this position will probably affect the secretion of IL-1α.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the correlation between the different genotypes at the position -889 in the promoter of interleukin-1 alpha(IL-1α) and the severity of coronary heart disease(CHD). Methods The genotypes of IL-1α(-889C/T)in 118 CHD patients and 184 healthy controls were analyzed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP), and The serum level of IL-1α was detected by enzyme-linked immunoabsorbent assay. Results The distribution of IL-1α (-889C/T) genotypes between myocardial infarction(MI) patients and healthy controls was significantly different (χ 2=5.96, P 0.01). CT or TT genotype carriers were at increased risk with an odds ratio of 2.39 for MI(OR=2.39, 95%CI=1.17~4.86). In CHD group, the IL-1α level in patients with CT genotype (13.51±6.85) ng/L was significantly higher than those with CC genotype[(8.04±4.47) ng/L; P 0.001].Conclusion The CT genotype at position -889 in IL-1α is associated with the severity of CHD, and the DNA mutation at this position will probably affect the secretion of IL-1α.
Key concepts: Genotype, Restriction fragment length polymorphism, Gastroenterology, Internal medicine, Odds ratio, Myocardial infarction, Interleukin, Interleukin 6